RoSS.PADL Homogenizing Solution
KUFSTEIN, Austria, Jan. 19, 2023 (GLOBE NEWSWIRE) — Emerging process solution provider Single Use Support has launched RoSS.PADL, an unprecedented platform system for standardizing homogenization and cooling of liquid pharmaceuticals.
RoSS.PADL optimizes fluid homogeneity through massaging and cooling single-use bags of any size. It ensures uniformity of the entire production batch with cGMP-compliant automation prior to dispensing into smaller single-use bioprocess containers. The seamless integration of this platform adds a reproducible and reliable step toward end-to-end fluid management processes. It eliminates the need for human intervention and with it the risk of single-use bag handling errors.
Newly automated process step
Bernhard Schlichtner, Chief Commercial Officer at Single Use Support, confirms several pre-orders for RoSS.PADL. “The combination of homogenization and cooling between 2°C and 8°C (35.6°F and 46.4°F) is unique and supports the resolution of increased aggregation of biologics and cells, e.g., during cell suspension. It eliminates the need for small mixing bags with impellers or manual intervention and advances the movement of liquids in a controlled manner during the aseptic filling process.” The single-use-bag-agnostic platform system maintains a closed system and simplifies the fluid management process.
With Single Use Support’s modular process solutions for sterile filling–draining, freezing–thawing and its protective solutions that cover the entire storage and shipment processes, the homogenizing system optimizes the fluid management of high-value liquid drug substances.
More about RoSS.PADL: https://www.susupport.com/solutions/platform-systems/freeze-thaw-system/homogenizer
Press contact
Michael Eder
m.eder@susupport.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/afa1b464-da10-4f0f-8ab1-e72ee571bfc1
Milestone enables GMP manufacturing to accelerate clinical trials and transform global vaccine delivery BRISBANE, Australia…
BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading…
12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel…
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…
The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process…